Pharma IQ Members

Medical Devices and Diagnostics

The medical device industry continues to see healthy growth, especially the in vitro diagnostics market. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in the bio-pharmaceutical and medical device industry to exchange ideas on best practice and share case studies on innovation within the area.

Contributor: Chanice Henry
Posted: 16/05/2017
Ransomware attack could be wake-up call the healthcare sector needs to grasp importance of cyber security and the catastrophic cost of ignoring its threat Full Article »
Contributor: Andrea Charles
Posted: 16/06/2013
The FDA Final Rule on UDIs is a critical move forward in utilising and leveraging technology to advance medical device information. In this exclusive interview Dawn Fowler, Sr. Manager, Labeling & Documentation at Endologix, speaks to Andrea Charles from Pharma IQ, about the importance of real world assessment in executing UDI programs and  Full Podcast »
Contributor: Regina Au
Posted: 23/03/2015
Regina Au
In the medtech world, the boundaries between the semiconductor and medtech industries have already been blurred with chips, sensors and Micro-Electro-Mechanical Systems (MEMS). Today, the boundaries between high tech and medtech are starting to blur as well. Large high tech companies such as Google, Microsoft are trying to expand into the medtech market and large medtech companies such as Philips Healthcare, Medtronic, Roche are trying to use the expertise of these high tech companies to further innovation in the medical field to improve patient care in both medical devices and e-health. So who's partnering with whom? Full Column »
Posted: 20/12/2016
Software design, medical devices, med devices, software for medical devices, medical software, apps
The Medical Device Technologies Market is forecasted to undergo exponential growth from 2015 up to 2021. Forecasted global market value for emerging medical device technologies by 2021: £90.8bn This is from 2016’s valuation of $55.9 billion Full Whitepaper »